| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q04DX003 (ip) | median survival time | saline | 13.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 21.6 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 36.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 100.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |